论文部分内容阅读
目的 探讨肝癌介入治疗后期综合疗法的临床效果。材料与方法 对 33例肝癌介入治疗后期综合症状采取一系列综合措施 :出血应用凝血酶原复合物 ;肝性脑病应用支链氨基酸等方法治疗。结果 2 1例PCS术后留置管全部保持通畅。 33例平均生存期 2 0 .1个月 ,2年生存率为 36%。结论 对肝癌介入治疗后期采取一系列综合措施 ,可延长患者生存期 ,提高生存质量 ,使肝癌介入治疗效果上一个新台阶。
Objective To explore the clinical effect of comprehensive therapy in late interventional treatment of liver cancer. Materials and Methods A series of comprehensive measures were taken for 33 patients with hepatocellular carcinoma at the late stage of interventional syndrome: hemorrhagic prothrombin complex; hepatic encephalopathy with branched-chain amino acid and other methods. Results All the indwelling tubes of 21 cases of PCS remained unobstructed. The average survival time of 33 cases was 2.01 months, and the 2-year survival rate was 36%. Conclusion Adopting a series of comprehensive measures in the later stage of interventional treatment of liver cancer can prolong the survival period of patients, improve the quality of life, and make the effect of interventional treatment of liver cancer a new level.